Found: 36
Select item for more details and to access through your institution.
Pre- and Intraoperative Visualization of GRPR-Expressing Solid Tumors: Preclinical Profiling of Novel Dual-Modality Probes for Nuclear and Fluorescence Imaging.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2161, doi. 10.3390/cancers15072161
- By:
- Publication type:
- Article
Radiolabeled Bombesin Analogs.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5766, doi. 10.3390/cancers13225766
- By:
- Publication type:
- Article
Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [ 111 In]In-DOTATATE Uptake in NET Cells.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4905, doi. 10.3390/cancers13194905
- By:
- Publication type:
- Article
Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1100, doi. 10.3390/cancers13051100
- By:
- Publication type:
- Article
Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0171343
- By:
- Publication type:
- Article
Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170536
- By:
- Publication type:
- Article
In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00283-x
- By:
- Publication type:
- Article
Safety of [<sup>177</sup>Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4440, doi. 10.1007/s00259-022-05926-2
- By:
- Publication type:
- Article
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4616, doi. 10.1007/s00259-022-05870-1
- By:
- Publication type:
- Article
In memoriam: Marion Hendriks-de Jong.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1339, doi. 10.1007/s00259-020-05057-6
- By:
- Publication type:
- Article
Epigenetic regulation of SST<sub>2</sub> expression in small intestinal neuroendocrine tumors.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1184436
- By:
- Publication type:
- Article
GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1199432
- By:
- Publication type:
- Article
DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061555
- By:
- Publication type:
- Article
The Balance Between the Therapeutic Efficacy and Safety of [<sup>177</sup>Lu]Lu-NeoB in a Preclinical Prostate Cancer Model.
- Published in:
- Molecular Imaging & Biology, 2024, v. 26, n. 1, p. 114, doi. 10.1007/s11307-023-01851-4
- By:
- Publication type:
- Article
In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapy‐ naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapy‐ naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
Review: Receptor Targeted Nuclear Imaging of Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 260, doi. 10.3390/ijms18020260
- By:
- Publication type:
- Article
Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 195, doi. 10.3390/pharmaceutics14010195
- By:
- Publication type:
- Article
The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 173, doi. 10.3390/pharmaceutics14010173
- By:
- Publication type:
- Article
Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 674, doi. 10.3390/pharmaceutics13050674
- By:
- Publication type:
- Article
The Use of a Non-Conventional Long-Lived Gallium Radioisotope 66 Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 292, doi. 10.3390/pharmaceutics13020292
- By:
- Publication type:
- Article
Preclinical Evaluation of 99m Tc-Labeled GRPR Antagonists maSSS/SES-PEG 2 -RM26 for Imaging of Prostate Cancer.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 182, doi. 10.3390/pharmaceutics13020182
- By:
- Publication type:
- Article
Therapeutic Applications of Pretargeting.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 9, p. 434, doi. 10.3390/pharmaceutics11090434
- By:
- Publication type:
- Article
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 8, p. 1072, doi. 10.3390/ph16081072
- By:
- Publication type:
- Article
SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 10, p. 1609, doi. 10.2967/jnumed.116.189035
- By:
- Publication type:
- Article
<sup>68</sup>Ga/<sup>177</sup>Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 2, p. 293, doi. 10.2967/jnumed.116.176636
- By:
- Publication type:
- Article
Comparison of the Therapeutic Response to Treatment with a <sup>177</sup>Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 260, doi. 10.2967/jnumed.115.167007
- By:
- Publication type:
- Article
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 10, p. 1487, doi. 10.2967/jnumed.115.160739
- By:
- Publication type:
- Article
In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 5, p. 752, doi. 10.2967/jnumed.114.153023
- By:
- Publication type:
- Article